skip to content

[Ad hoc announcement pursuant to Art. 53 LR] Roche’s strong sales growth of 9% (CER) continues in the third quarter of 2024; Group sales increase 6% in the first nine months

Media

Media releases
view all

stay updated

get the latest news and updates to your inbox.